Stocks
Axsome Therapeutics (AXSM) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 0.29 | 0.61 | 0.89 | 0.45 | 0.49 | 0.51 | |||
| Changes by years, y/y, % | -78% | +105% | +47% | -49% | +8% | -18.5% | |||
Axsome Therapeutics. Debt/EBITDA
Axsome Therapeutics. Debt/EBITDA, changes, %
Axsome Therapeutics (AXSM) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| Debt/EBITDA | 0.34 | 0.38 | 0.50 | 0.49 | 0.51 | 0.51 | ||
| Changes by years, y/y, % | -31% | -10% | +11% | +9% | +50% | |||
| Changes by quarters, q/q, % | -24% | +10% | +34% | -2% | +4% | |||
